FIELD: medicine; veterinary.
SUBSTANCE: invention relates to human and veterinary medicine, namely to means for dissolution of bile stones and treatment of cholelithiasis. Agent for dissolution of bile stones and treatment of cholelithiasis contains mixture of varied polyprenyl phosphates and/or polyprenyl pyrophosphates of vegetal origin with number of isoprene links from 7 to 30. Agent can be absorbed on solid sorbent, in particular sorbitol, lactose, starch, and can contain beta-sitosterol.
EFFECT: technical result from use of proposed drug consists in possibility of dissolution of bile stones and treatment of cholelithiasis with no adverse reactions.
12 cl, 7 dwg, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATING METABOLIC SYNDROME | 2014 |
|
RU2580757C1 |
METHOD FOR TREATING CHOLELITHIASIS | 1992 |
|
RU2045956C1 |
METHOD OF PROPHYLAXIS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CHOLELITHIASIS AFTER LAPAROSCOPIC CHOLECYSTECTOMY | 2017 |
|
RU2657838C1 |
METHOD FOR TREATING PATIENTS, SUFFERING FROM CALCULOUS CHOLECYSTITIS WITHOUT BILE DISCHARGE DISORDERS VIA COMMON BILE DUCT, FOR HYPERBILIRUBINEMIA | 2004 |
|
RU2252715C1 |
REMEDY FOR PREVENTION AND TREATMENT OF METABOLIC SYNDROME | 2022 |
|
RU2806867C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR CHOLELITHIASIS, CHOLESTEROSIS AND GALL BLADDER POLYPS | 2008 |
|
RU2367353C1 |
CHOLELITOLAPAXY METHOD | 2021 |
|
RU2762207C1 |
METHOD OF TREATING CHOLELITHIASIS IN EXPERIMENT | 2013 |
|
RU2535150C2 |
METHOD FOR TREATING THE CASES OF CHOLELITHIASIS BY MEANS OF DOLPHIN THERAPY | 1999 |
|
RU2149658C1 |
METHOD FOR DIAGNOSING CHOLESTASIS DEVELOPMENT DUE TO ACUTE VIRAL HEPATITIS | 1998 |
|
RU2159080C2 |
Authors
Dates
2016-12-20—Published
2015-12-02—Filed